Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lofty Launches MCP Server to Give Brokerages an Open Foundation for Their AI Strategy
-
Latin Metals Receives C$1.875 Million from Warrant Exercises
-
Latin Metals Receives C$1.875 Million from Warrant Exercises
-
Alaris Equity Partners Announces Closing of $115 Million Bought Deal Offering
-
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
-
iSpring Kicks Off Its 2026 Fall Sale Featuring Reliable Water Filtration Solutions as Households Prepare for Seasonal Home Refreshes
-
iSpring Kicks Off Its 2026 Fall Sale Featuring Reliable Water Filtration Solutions as Households Prepare for Seasonal Home Refreshes
-
Borregaard ASA: Refinancing of long-term sustainability linked credit facilities
-
Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law
-
Foresight Plans to Acquire 50.01% in a 270MW Capacity European Data Center Development Company
-
Phillips Edison & Company Inc. Invites You to Join Its Third Quarter 2026 Earnings Conference Call
-
Traction Uranium Commences Drilling at the Aurora Uranium Project
-
Kaltura Wins Best Interactive Content Platform in the 2026 Digiday Technology Awards
-
ORYZON Receives European Medicines Agency Approval to Initiate the HOPE-2 Phase II Study of Vafidemstat for the Treatment of Phelan-McDermid Syndrome (PMS)
-
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
-
GuideAI Health Corp. and vRad Renew Data Exclusivity Agreement to Develop AI Models for the Detection and Characterization of Multiple Vascular Diseases
-
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
-
Aemetis Receives $22.4 million from Sale of Section 45Z Clean Fuel Production Tax Credits
-
ReconAfrica Resumes Operations at Kavango West 1X Ahead of Horizontal Flow Test and Provides Updates on KW1X Flow Test Samples, Angola Soil Sampling and Gabon Seismic Reprocessing
-
Core Molding Technologies Promotes Michael J. Gayford to Chief Operating Officer
-
COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR
-
Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik
-
GOWell Energy Technology Commences Trading on Nasdaq Under Ticker Symbol "GOW”
-
Paychex Earns 5-Star Rating on Newsweek's America's Greatest Companies 2026 List
-
Genius Group Announces 140% Increase in Revenue, $6.4 Million Net Profit from Operating Units, 79% Reduction in Total Net Loss in First Half of 2026
-
Astro Digital, Premier Builder of Satellites for Commercial, Civil and Defense Applications, to Become Public Through Merger with Proem Acquisition Corp I
-
Fobi AI (TSXV: FOBI) Issues Corporate Update on Business Transition; Schedules Live Product Demo for October 7
-
Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer
-
NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212
-
GOWell Energy Technology Commences Trading on Nasdaq Under Ticker Symbol "GOW”
-
Harvard Ave Acquisition Corporation and OAG International Ltd Announce Definitive Business Combination Agreement
-
NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes
-
Newtek Bank Expands Connected Banking Capabilities Across Leading Accounting and Business Applications
-
icMercury Selected for In-Orbit Validation Mission Aboard PocketQube Satellite on SpaceX Transporter-18
-
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
-
DFDV Grows SOL Treasury 10% in Just 6 Weeks, Surpassing 2.5 Million SOL Held
-
Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
-
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
-
Tim Swiat Joins Monarch Private Capital as Director of Placement, Colorado
-
Safe Harbor Financial Announces the Implementation of a Reverse Stock Split
-
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
-
Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden
-
NETSOL Technologies reports record fiscal 2026 revenue and full-year profitability, exceeding guidance
-
ROC Secures $64.3 Million U.S. Department of Justice Contract for Digital Evidence Technology
-
Phillips Edison & Company Inc. Invites You to Join Its Third Quarter 2026 Earnings Conference Call
-
FTI Consulting Expands Italy Restructuring and Turnaround Capabilities With Senior Appointments
-
Paychex Earns 5-Star Rating on Newsweek's America's Greatest Companies 2026 List
-
COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR
-
Kaltura Wins Best Interactive Content Platform in the 2026 Digiday Technology Awards
-
Adhesion Wealth Launches Custom Model Solutions for RIAs
